Autolus Therapeutics plc
AUTL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001730463
In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Autolus Therapeutics plc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 67
- +3 vs. Q1 2022
- Shares held
- 50.8M
- −2.12M (−4.0%) vs. Q1 2022
- Total value
- $143.9M
- −$84.5M (−37.0%) vs. Q1 2022
- New holders
- 14
- 13 more added
- Sold out
- 11
- 18 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AUTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 83 | $212.0M |
| Q1 2026 | 84 | $184.4M |
| Q4 2025 | 89 | $277.1M |
| Q3 2025 | 96 | $235.7M |
| Q2 2025 | 94 | $378.6M |
| Q1 2025 | 95 | $261.0M |
| Q4 2024 | 110 | $395.4M |
| Q3 2024 | 101 | $648.5M |
| Q2 2024 | 111 | $620.0M |
| Q1 2024 | 120 | $1.12B |
| Q4 2023 | 99 | $746.6M |
| Q3 2023 | 71 | $258.1M |
| Q2 2023 | 69 | $260.4M |
| Q1 2023 | 65 | $195.1M |
| Q4 2022 | 71 | $204.2M |
| Q3 2022 | 66 | $105.7M |
| Q2 2022 | 67 | $143.9M |
| Q1 2022 | 66 | $228.6M |
| Q4 2021 | 73 | $272.3M |
| Q3 2021 | 59 | $164.2M |
| Q2 2021 | 69 | $169.6M |
| Q1 2021 | 63 | $129.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Autolus Therapeutics plc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 44 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 74 | $0 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Curi Capital | 137 | $0 | 0.00% | +137 | New |
| Exane Derivatives | 180 | $509 | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Carmichael Hill & Associates, Inc. | 508 | $1.00K | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 177 | $1.00K | 0.00% | −216−55.0% | Reduced |
| Northwestern Mutual Wealth Management Co | 500 | $1.00K | 0.00% | +500 | New |
| Bank of America Corp | 626 | $2.00K | 0.00% | −2,078−76.8% | Reduced |
| BNP Paribas Arbitrage, SA | 1,010 | $2.86K | 0.00% | +1,010 | New |
| Citigroup Inc | 957 | $3.00K | 0.00% | −279−22.6% | Reduced |
| Ulland Investment Advisors, LLC | 1,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Total Clarity Wealth Management, Inc. | 1,200 | $3.00K | 0.00% | +1,200 | New |
| Huntington National Bank | 1,501 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,454 | $10.0K | 0.00% | +480+16.1% | Added |
| Cannell Capital LLC | 4,001 | $11.0K | 0.00% | +4,001 | New |
| Group One Trading, L.P. | 5,900 | $17.0K | 0.00% | +100+1.7% | Added |
| Renaissance Technologies LLC | 12,800 | $36.0K | 0.00% | +12,800 | New |
| Blair William & Co | 13,341 | $38.0K | 0.00% | 00.0% | Unchanged |
| Weiss Multi-Strategy Advisers LLC | 13,753 | $39.0K | 0.00% | −723−5.0% | Reduced |
| Jane Street Group, LLC | 14,717 | $42.0K | 0.00% | +14,717 | New |
| Susquehanna International Group, LLP | 16,617 | $47.0K | 0.00% | +16,617 | New |
| American Portfolios Advisors | 16,925 | $47.9K | 0.00% | 00.0% | Unchanged |
| Bayshore Asset Management, LLC | 17,500 | $50.0K | 0.04% | +17,500 | New |
| Northeast Financial Consultants Inc | 19,672 | $56.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 21,039 | $60.0K | 0.00% | −354,475−94.4% | Reduced |
| Cubist Systematic Strategies, LLC | 21,487 | $61.0K | 0.00% | +21,487 | New |
| Boothbay Fund Management, LLC | 32,178 | $91.0K | 0.00% | −4,993−13.4% | Reduced |
| Acadian Asset Management LLC | 34,888 | $98.0K | 0.00% | +34,888 | New |
| Wealth Effects LLC | 38,100 | $108.0K | 0.07% | +6,450+20.4% | Added |
| UBS Group AG | 42,073 | $118.0K | 0.00% | −31,785−43.0% | Reduced |
| Alps Advisors Inc | 53,931 | $153.0K | 0.00% | −39,502−42.3% | Reduced |
| State Street Corp | 53,927 | $153.0K | 0.00% | −17,973−25.0% | Reduced |
| Legal & General Group Plc | 67,517 | $192.0K | 0.00% | +34,813+106.4% | Added |
| Morgan Stanley | 68,383 | $194.0K | 0.00% | −106,876−61.0% | Reduced |
| Caxton Associates LP | 89,356 | $253.0K | 0.03% | 00.0% | Unchanged |
| Privium Fund Management B.V. | 98,528 | $279.0K | 0.09% | +65,528+198.6% | Added |
| MYDA Advisors LLC | 100,000 | $283.0K | 0.12% | −15,000−13.0% | Reduced |
| Erste Asset Management GmbH | 120,000 | $339.6K | 0.01% | 00.0% | Unchanged |
| Cetera Investment Advisers | 127,000 | $359.0K | 0.01% | +2,700+2.2% | Added |
| Geode Capital Management, LLC | 133,438 | $377.0K | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 149,035 | $422.0K | 0.01% | +149,035 | New |
| Harbor Capital Advisors, Inc. | 164,906 | $467.0K | 0.36% | +1,763+1.1% | Added |
| Millennium Management LLC | 237,659 | $673.0K | 0.00% | +70,093+41.8% | Added |
| Ikarian Capital, LLC | 322,217 | $912.0K | 0.38% | −50,000−13.4% | Reduced |
| Wells Fargo & Company | 363,955 | $1.03M | 0.00% | +124,320+51.9% | Added |
| MAI Capital Management | 365,407 | $1.03M | 0.02% | +365,407 | New |
| FMR LLC | 380,185 | $1.08M | 0.00% | −1,262,100−76.9% | Reduced |
| Cormorant Asset Management, LP | 392,167 | $1.11M | 0.09% | 00.0% | Unchanged |
| BlackRock Inc. | 467,846 | $1.32M | 0.00% | +81,132+21.0% | Added |
| DAFNA Capital Management LLC | 496,150 | $1.40M | 0.38% | 00.0% | Unchanged |
| LGT Capital Partners Ltd. | 550,000 | $1.56M | 0.05% | +50,000+10.0% | Added |
| UBS Oconnor LLC | 584,246 | $1.65M | 0.02% | +584,246 | New |
| Capital World Investors | 625,000 | $1.77M | 0.00% | −435,579−41.1% | Reduced |
| JPMorgan Chase & Co | 626,519 | $1.77M | 0.00% | −173,039−21.6% | Reduced |
| Alphabet Inc. | 698,262 | $1.98M | 0.11% | 00.0% | Unchanged |
| Woodline Partners LP | 726,114 | $2.06M | 0.03% | −69,897−8.8% | Reduced |
| Pendal Group Limited | 1,365,429 | $3.86M | 0.04% | −9,677−0.7% | Reduced |
| Schroder Investment Management Group | 1,672,732 | $4.73M | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,153,657 | $6.09M | 0.01% | −1,358,856−38.7% | Reduced |
| Polygon Management Ltd. | 3,019,413 | $8.54M | 0.60% | +193,476+6.8% | Added |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $10.6M | 1.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 5,142,855 | $14.6M | 1.26% | +796,528+18.3% | Added |
| Syncona Portfolio Ltd | 7,346,829 | $20.8M | 29.54% | 00.0% | Unchanged |
| Blackstone Group Inc. | 17,985,611 | $50.9M | 0.17% | 00.0% | Unchanged |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −382,559−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −371,540−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −27,536−100.0% | Sold out |
| Moloney Securities Asset Management, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −15,074−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −11,869−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −3,087−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −982−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −301−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −346−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Golden State Equity Partners | – | – | – | – | Not filed |